Research at the Duncan Cancer Center

Our Vision

news-120414-bladder-cancer2 (320x240)
Dr. Keith Syson Chan, Antonina Kurtova and Dr. Jing Xiao.

With the largest clinical genetics program housed at Baylor Clinic, our vision for a future of personalized medicine is quickly becoming a reality. As an academic-based center, the Duncan Cancer Center at Baylor College of Medicine offers cutting-edge, research-based treatment options such as using patients' own genetic makeup to identify their potential for cancer, prevent its onset, more effectively diagnose and treat the disease when it does occur, and one day, provide a cure.

We’re bringing our vision to life through the continued pursuit of genomic research and the rapid translation of new discoveries into improved patient care.

Research Programs

The Dan L Duncan Comprehensive Cancer Center has organized its research activities into seven programs to enhance interactions between investigators.

These programs are supported by many sources of funding including philanthropy but are primarily funded through competitive research grants from the NCI and other institutes of the NIH.

Disease-oriented Working Groups

The Duncan Cancer Center also has disease-oriented working groups focused on particular cancer types. These multi-disciplinary groups bring together clinicians and investigators to translate scientific findings into coordinated patient care. These groups may work within or across our formal research programs.  

  • Brain/Neuro-oncology
  • Endocrine
  • Esophageal
  • Gastrointestinal
  • Genitourinary/Prostate
  • Gynecological

  • Head and Neck
  • Hematological
  • Human Cancer Genetics
  • Liver
  • Lung/Thoracic
  • Pancreatic

Inside Our Research Programs

The ever evolving fight against cancer

The Cancer Evolvability Program creates a gateway between clinicians and basic scientists who are working toward more precise testing, treatment and cures for cancer.

Dissecting the motor of cancer

Dr. Bert O'Malley's passion for understanding how human cells works leads to insight in developing new therapies to treat breast cancer.

Mapping cancer's genome

The goal of the nine-year Cancer Genome Atlas Project is to identify genetic changes and variations found in more than 20 types of cancer.